Professor John Newton, Director of Health Improvement at Public Health England, describes how the agency regularly provides insights and ideas to the annual Global Burden of Disease Study, and uses information from the study to influence health policy.
Professor Shuhei Nomura of the Department of Health Policy and Management at Keio University in Japan shares how he uses Global Burden of Disease Study data to advance health policy for prefectures, nationwide nutrition, and resource allocation.
Professor Peter Keiyoro of the University of Nairobi in Kenya, a collaborator of the Global Burden of Disease Study for six years, describes how the GBD has guided the Kenyan government into a national universal health coverage program. Additionally, GBD data laid the foundation for the Kenyan government to launch a pilot program that addresses water availability, sanitation, nutrition, child hygiene, under-five mortality, maternal health, and insurance coverage and health policies.
Dr. Cristiana Abbafati is a health economist at the University of Sapienza in Rome and a collaborator with the Global Burden of Disease Study. She utilizes GBD resources to better understand the relationship between Type II Diabetes, healthcare costs, and developmental levels in EU countries in order to recommend future health policies.
Global Burden of Disease Study, convened by the Institute for Health Metrics and Evaluation, is the most comprehensive global health study to date. It analyzes 286 causes of death, 369 diseases and injuries, and 87 risk factors in 204 countries and territories.
Director-General of the World Health Organization, Dr. Tedros Adhanom Ghebreyesus, introduces the Global Burden of Disease Study 2019.
El director de IHME y principal modelador de COVID-19, el Dr. Christopher J.L. Murray, explica qué es la inmunidad colectiva y por qué es poco probable que las comunidades hayan alcanzado la inmunidad colectiva, y ciertamente no se ha alcanzado en los Estados Unidos ni en Europa.
Disha Patel, IHME Software Development Manager, explains how to use our COVID-19 model's "scenarios" feature, which helps policymakers understand how different policy decisions could affect the course of the pandemic.
Herd immunity is not an effective strategy for addressing the COVID-19 pandemic. IHME Director and lead COVID-19 modeler Dr. Christopher Murray busts myths about the strategy and provides insights on more effective solutions to the global crisis.
Dr. Christopher J.L. Murray discusses key assumptions behind our COVID-19 model's forecast of a winter surge in COVID-19 deaths: seasonality and declining vigilance with mask-wearing and social distancing.
IHME Director Dr. Christopher J.L. Murray discusses a key assumption in IHME's COVID-19 model as of September 3, 2020 — seasonality.
Universal health coverage is defined as all people receiving quality health services without incurring financial hardship. The paper, part of the Global Burden of Disease study, was published today in the international medical journal The Lancet. Researchers focused only on measuring service coverage, developing a new framework to capture how well countries align health services with the needs of the population and how well or poorly those services contribute to people’s health.
Dr. Angela Michah introduces the 2019 Financing Global Health report and explains key topics.
Learn how to explore trends in health spending worldwide with our 2019 Financing Global Health visualization tool.
IHME Director Dr. Christopher J.L. Murray is the co-author of the GBD paper "Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100." Dr. Murray discusses economic trends in the coming century.
Most countries outside of sub-Saharan Africa are projected to enter a period of sustained low fertility and a decline in the working age populations. Speakers Drs. Natalia Kanem and Christopher Murray discuss the drivers of declining fertility rates in many regions of the world as well as their social, economic, fiscal, and national security implications.
Dr. Richard Horton, Editor-in-Chief of "The Lancet", discusses the paper "Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100."
A new study from the Institute for Health Metrics and Evaluation, titled "Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study" estimates the global population in 2100, including four alternative scenarios based on progress toward two key drivers of fertility rates: women’s education, and access to reproductive health.
Check out the new alternative scenarios in our COVID-19 Projections tool.
An animation depicting change in mask use worldwide from April 26 to June 2, 2020.
Get the most out of our COVID-19 Projections tool with this short tutorial.
Dr. Chris Murray of the Institute for Health Metrics and Evaluation explains a new focus on forecasting possible relaxation of social distancing.
IHME Editorial Coordinator, Rebecca Sirull, talks about her experience participating in a clinical trial for a potential COVID-19 vaccine.
Dr. Christopher Murray, Director of the Institute for Health Metrics and Evaluation, describes the trajectory of the first wave of the COVID-19 pandemic based on new data analyses and forecasting.
Preparedness is key when tackling a novel pathogen like 2019-nCoV. Dr. David Pigott, assistant professor and spatial epidemiologist at IHME, discusses the importance of prevention, detection, and treatment in response to an epidemic.